
Sarcoma Service at Memorial Sloan Kettering
@msksarcoma
For more than 135 years, we have been united by a singular purpose: to find cures for sarcomas.
1-844-923-0361 (new pts) | [email protected] (doctors)
ID: 1281994605962158085
https://www.mskcc.org/cancer-care/types/soft-tissue-sarcoma 11-07-2020 16:51:54
114 Tweet
695 Followers
292 Following


Our latest work is out in Nature Communications. With Francisco Sanchez-Vega, William Tap, Samuel Singer, and colleagues at Sarcoma Service at Memorial Sloan Kettering Memorial Sloan Kettering Cancer Center, we present a genomic analysis of 2,138 tumors representing 45 subtypes of soft tissue and bone #sarcoma (1/x). 🧵 disq.us/t/48gjq1m

Nivolumab with bempegaldesleukin in sarcoma now published in Nature Communications. A collaborative effort with my colleagues Sarcoma Service at Memorial Sloan Kettering, William Tap, MSK computational biologists (Allison Richards, Mark Donoghue) and MDA colleagues Anthony P Conley) nature.com/articles/s4146… Memorial Sloan Kettering Cancer Center 1/8





MSK fellow extraordinaire, Dr. Lauren Banks provides insightful perspective into the status of immunotherapy for sarcoma. Privileged to co-mentor with Dr. Klebanoff with whom she's conducting ground breaking research Klebanoff_Lab William Tap MSK Department of Medicine

Mrs. Michelle Obama has received nearly 2,000 letters every month — which are part of the inspiration behind her new book “The Light We Carry.” Take a look at the story of one woman who wrote a letter in 2020 and found comfort in Mrs. Obama’s words during a difficult time.

Nirogacestat, a New Desmoid Tumor Treatment, Improves Outcomes for People With Sarcoma mskcc.org/news/nirogaces… Aimee Crago, M.D. Dr. Sam Singer, MSK, Dr. Joe Erinjeri, Dr. Robert Lefkowitz Desmoid Tumor Research Foundation American Cancer Society SpringWorks National Organization for Rare Disorders (NORD) Deborah Schrag

As a recipient of numerous ASCO Conquer Cancer grants, I can attest to the power and value of these opportunities. connection.asco.org/magazine/featu…. Sarcoma Service at Memorial Sloan Kettering MSK Department of Medicine ASCO Conquer Cancer, the ASCO Foundation


Dr. Kelly shows that pembrolizumab + epacadostat is ineffective in #sarcoma but correlative studies noted lack of IDO inhibition. Provides some important insight into potential mechanism of drug failure, leaving many unanswered questions. Sarcoma Service at Memorial Sloan Kettering MSK Department of Medicine

On 4/26, we're launching a global educational series on molecular oncology, co-directed by MSK's Dr. Mrinal Gounder and Sewanti Limaye 🇮🇳🇺🇸 of Sir H. N. Reliance Foundation Hospital Mumbai, to examine cancer signaling pathways and discuss nuances of precision therapies. Register today! bit.ly/3oDMGpS?utm_ca…

"This grant is meaningful to me because it allows me to continue my research which is focused on novel immunotherapies for rare pediatric cancers," shares CRI-Bristol Myers Squibb Fellow Dr. Lauren Banks of Memorial Sloan Kettering Cancer Center. Learn more: bit.ly/3LFpFwv #CancerResearch


Featured today by MSK Library: A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma dx.doi.org/10.1158/1078-0…

The July episode of #SARCTalk features Dr. Mark Dickson, MD from Memorial Sloan Kettering Cancer Center sharing valuable insight on #liposarcoma. Listen now on Spotify! Also available on Apple Podcast and YouTube. open.spotify.com/episode/5WfZmK… #sarcoma #SARCtrials Sarcoma Service at Memorial Sloan Kettering